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Chemoimmunosuppressive agents (1), alkylating agents (nitrogen
mustard and cyclophosphamide), purine antagonists (6 mercapto purine
(2-4) and azothioprine (5» and folic acid analog (amethopterin), are
widely used as drugs for therapy of "autoimmune" diseases such as pro-
gressive hepatitis (6) and rheumatoid-arthritis (7).
As these agents are mostly antimetabolites (8), they are much toxic to
the patients. Therefore, it is necessary to select less toxic chemicals, yet
maintaining their immunosuppressive activity.
Thioinosine, 6 mercaptopurine riboside (MW, 284.29) having 6-mer-
captopurine (6-MP) residue in its chemical structure is considered to have
immunosuppressive effect. As to the toxicity of thioinosine, LD50 for mice
is about 2500 mgjkg by intraperitoneal injection (9) and in comparison
with that of 6-mercaptopurine, 380 mgjkg, the toxicity of thioinosine is
extremely low. However, there is no report concerning immunosuppressive
effect of thioinosine.
We investigated the effect of thioinosine on antibody production of
rabbit injected with bovine serum albumin. This report describes briefly
our results.
MATERIALS AND METHODS
Fifteen white New Zealand strain rabbits weighing about 3 kg and kept in a
stock ad libitum diet were used. On Experiment 1, 3 rabbits were used as control
group, 4 as thioinosine treated group, and 4 as 6.MP treated group. On Experi.
ment 2,2 rabbits were used as control, and 2 were as thoinosine treated group.
All animals were injected intramuscularly with 70 mg of crystalline bovine
albumin (Nutritional Biochemicals Corporation), on Experiment 1, and with 100
mg on Experiment 2, 3 times a week during 2 weeks. The experimental animals
were given 6.MP (Zellstoffabrik, "Waldhof"), 3.0 mg/kg/day, or thioinosine 5.4
mg/kg/day (mole equivalent) intramuscularly according to the schedule. Blood
was drawn from a marginal ear vein at appropriate intervals. Antibody titer was
measured by antigen antibody dilution method.
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RESULTS
Experiment 1: Rabbits were given thioinosine from 0 day to 23 days,
showed no detectable antibody during the 23 days of the study as shown
in Table 1, one rabbit out of 4 was dead during the experiment. In the
TABLE 1. COURSE OF THE FIRST IMMU:-;E RESPONSE IN CONTROL, AND THIOINOSINE AND
6-:lip TREATED RABBITS. (EXPRESSED AS ANTIBODY TITER)
date (D/M) 16/2 27/2 4/3 10/3
method days after first 170 12 23
injection
No. 1 0 0 0 4
control
No. 2 0 0 0 8
rabbits
No. 3 0 0 0 1
No. 4 0 0 0 0
thioinosine No. 5 0 0 0 0
treated No. 6 0 0 0 0
rabbits
No. 7 0 dead* dead dead
No. 8 0 0 0 0
6-MP treated No. g 0 0 dead dead
rabbits No. 10** 0 0 0 0
No. 11 0 0 dead dead
Antigen (bovine serum albumin 70 mg/once) was injected on zero, third, fifth, eighth,
tenth and twelfth respectively. Thioinosine (5.4 mg/kg/day) or 6-MP (3.0 mg/kg/day)
was injected every day.
* died on February 25th. ** died on March 12th.
case of 6·MP treated rabbits by the same schedule, antitody production
was not detected. In this case, 2 rabbits out of 4 were dead. Three control
rabbits injected with only bovine serum albumin showed 1 : 1, 1: 4 and
1 : 8 of antibody titer respectively 23 days after the first injection of anti-
gen.
Experiment 2: Rabbits were injected with bovine serum albumin, 5
times every day, and 31 days after the first injection average antibody
titer showed 1 : 8 as shown in Fig.!. Then antibody titer decreased to 1 : 4
and 1 : 2 on 40 days after the first injection of bovine serum albumin.
Rabbits were injected with bovine serum albumin 3 times at 2 days'
interval from 43 to 47 days and thioinosine was administered from 31 to
51 days after the first injection. Average antibody titer in the serum of
thioinosine treated rabbits shows only 1 : 1 on 53th day. In contrast to this,
the control group without being treated by thioinosine showed 1 : 32 of
average antibody titer.
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Fig. I Course of immune response in control and thioinosine treated rabbits.
Each vertical arrow represents antigen injection. Time of administration of thioino-
sine is represented by the clear block. Antibody titer of 0 day is below I : 1.
DISCUSSION
The data described herein demonstrate that thioinosine, its 6-MP
residue, convinced us of the powerful nucleic acid antimetabolite,
abolishes the humoral antibody production in the rabbits to bovine serum
albumin when given simultaneously with the antigen. As to the site of
action of thioinosine with respect to antibody formation, suppression of
protein synthesis in immunoblasts or plasmacytes or that of RNA synthesis
in memory cells can be considered to be present.
SCHWARTZ and DAMESHEK (3) described the drug induced immunolo-
gical tolerance. On the other hand, GOH et al. (0) reported that it was
not possible to produce immunological tolerance in rabbits pretreated with
6-MP by injection of human serum r-globulin, and ARGANO and TOBIN (4)
described similar phenomena to GOH with 6-MP by injection of human
serum albumin. The results of GOH and ARGANO suggeH that the effect
of 6-MP on antibody synthesis will be described as "temporary suppre3sion
of antibody synthesis". It is inferred that the mechanism of thioinosine to
antibody synthesis will be similar to 6-MP from its chemical structure,
though its metabolic pathway* should be investigated. Studies to deter-
mine the mechanism of thioin03ine with relation to 6-MP as well as its
* It is considered that 6-\1P competes with hypoxanthine for inosinic acid pyrophosphorylase
and itself reacted v. ith PRPP and converted to thioinosinic acid (11MI') (II). 1 his nucleotide
inhibits several reactions involving inosinic acid: the conversion to xanthylic acid (XMP)
and the conversion to aden)lic acid (AM}) via adenylosuccinate (SAMP) (12). However
the mechanisms of thioinosine on nucleic acid biosynthesis is not completely clear.
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effects on the secondary response and on the immune response to cellular
antibody are in progress.
CONCLUSION
The effect of thioinosine on antibody response of immunized rabbits
has been studied. When given simultaneously with the antigen, thioinosine
profoundly suppresses the formation of humoral antibody.
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